149
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Bronchial Artery-Pulmonary Artery Shunt by Apiotrichum mycotoxinivorans Infection in a Recurrent Hemoptysis Case

ORCID Icon, ORCID Icon, , , &
Pages 4611-4615 | Published online: 18 Aug 2022

References

  • Liu XZ, Wang QM, Goker M, et al. Towards an integrated phylogenetic classification of the Tremellomycetes. Stud Mycol. 2015;81:85–147.
  • Molnar O, Schatzmayr G, Fuchs E, Prillinger H. Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins. Syst Appl Microbiol. 2004;27(6):661–671.
  • Hickey PW, Sutton DA, Fothergill AW, et al. Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. J Clin Microbiol. 2009;47(10):3091–3097.
  • Hirschi S, Letscher-Bru V, Pottecher J, et al. Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient. J Clin Microbiol. 2012;50(12):4168–4170.
  • Almeida JN, Francisco EC, Barberino M, et al. Emergence of Trichosporon mycotoxinivorans (Apiotrichum mycotoxinivorans) invasive infections in Latin America. Mem Inst Oswaldo Cruz. 2017;112(10):719–722.
  • Peng L, Jiang YQ, Jiang GM, et al. Molecular identification and biological characteristic analysis of an Apiotrichum mycotoxinivorans (formerly Trichosporon mycotoxinivorans) strain isolated from sputum specimens of a pediatric patient with pneumonia. J Mycol Med. 2019;29(2):120–126.
  • Sadamatsu H, Takahashi K, Tashiro H, et al. A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung. J Infect Chemother. 2020;26(8):838–842.
  • Shah AV, McColley SA, Weil D, Zheng X. Trichosporon mycotoxinivorans infection in patients with cystic fibrosis. J Clin Microbiol. 2014;52(6):2242–2244.
  • Goldenberger D, Hinic V, Prince SS, et al. A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method. BMC Infect Dis. 2016;16(1):601.
  • Martinez Muniz Fde B, Martinez Redondo M, Prados Sanchez C, Garcia Rodriguez J. Chronic lung infection caused by Trichosporon mycotoxinivorans and tricosporin mucoides in an immunocompetent cystic fibrosis patient. Arch Bronconeumol. 2016;52(7):400.
  • Do Espirito Santo EPT, Monteiro RC, da Costa ARF, Marques-da-Silva SH. Molecular identification, genotyping, phenotyping, and antifungal susceptibilities of medically important Trichosporon, Apiotrichum, and Cutaneotrichosporon species. Mycopathologia. 2020;185(2):307–317.
  • Kröner C, Kappler M, Grimmelt A-C, Laniado G, Würstl B, Griese M. The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients – clinical analysis of Trichosporon positive patients in a Munich cohort. BMC Pulm Med. 2013;13(1):1–10.
  • Yon JR, Ravenel JG. Congenital bronchial artery-pulmonary artery fistula in an adult. J Comput Assist Tomogr. 2010;34(3):418–420.